| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.1M | +19.7% |
| Cost of Revenue | $17.2M | +35.3% |
| Gross Profit | $9.8M | -0.5% |
| R&D Expense | $1.2M | +21.3% |
| SG&A Expense | $13.5M | +19.1% |
| Operating Income | -$8.2M | -81.8% |
| Pre-tax Income | -$8.2M | -76.9% |
| Income Tax | $21K | -8.6% |
| Net Income | -$8.2M | -73.3% |
| EPS (Basic) | -$0.30 | -57.9% |
| EPS (Diluted) | -$0.30 | -57.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | +130.0% |
| Accounts Receivable | $4.3M | -29.0% |
| Inventory | $10.9M | +13.7% |
| Current Assets | $28.9M | +30.4% |
| Total Assets | $37.0M | +19.0% |
| Current Liabilities | $9.3M | -44.9% |
| Total Liabilities | $15.5M | -26.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | -344.1% |
| Capital Expenditures | $401K | -58.6% |
| Investing Cash Flow | -$464K | +54.3% |
| Financing Cash Flow | $17.4M | +1626.0% |
| Free Cash Flow | -$10.3M | -433.6% |
| $21.6M |
| +111.6% |